Open AccessA Promising, Novel Radiosensitizer Nanodrug Complex for Oral Cavity Cancer: Cetuximab and Cisplatin-Conjugated Gold Nanoparticles
Author(s) -
Şeniz İnanç Sürer,
Tarık Buğra Elçitepe,
D. Akçay,
Ezgi Daşkın,
Gizem Çalıbaşı Koçal,
Zümre Arıcan Alıcıkuş,
Görkem Eskıızmır,
Kerim Yapıcı,
Yasemin Başbınar
Publication year - 2021
Publication title -
balkan medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.398
H-Index - 16
eISSN - 2146-3131
pISSN - 2146-3123
DOI - 10.5152/balkanmedj.2021.21013
Subject(s) - cetuximab , radiosensitizer , cisplatin , radiation therapy , cancer research , cytotoxicity , viability assay , medicine , cancer cell , cancer , oncology , pharmacology , cell , chemistry , chemotherapy , in vitro , colorectal cancer , biochemistry
Nanomedicine has provided promising tools for the imaging, diagnosis, and treatment of cancer. Gold nanoparticles (GNPs) may be useful in enhancing the efficacy of radiotherapy, such as radiosensitization, in cancer therapy.